Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1993 1
1995 1
1997 4
1998 3
1999 10
2000 5
2001 5
2002 4
2003 1
2004 5
2006 5
2007 3
2008 2
2009 3
2010 7
2011 10
2012 4
2013 5
2014 8
2015 11
2016 8
2017 8
2018 9
2019 5
2020 6
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients.
de Man FM, van Eerden RAG, van Doorn GM, Oomen-de Hoop E, Koolen SLW, Olieman JF, de Bruijn P, Veraart JN, van Halteren HK, Sandberg Y, Moelker A, IJzermans JNM, Lolkema MP, van Gelder T, Dollé MET, de Bruin RWF, Mathijssen RHJ. de Man FM, et al. Among authors: de bruijn p. Clin Pharmacol Ther. 2021 May;109(5):1304-1313. doi: 10.1002/cpt.2094. Epub 2020 Dec 6. Clin Pharmacol Ther. 2021. PMID: 33119892
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.
Leblanc AF, Sprowl JA, Alberti P, Chiorazzi A, Arnold WD, Gibson AA, Hong KW, Pioso MS, Chen M, Huang KM, Chodisetty V, Costa O, Florea T, de Bruijn P, Mathijssen RH, Reinbolt RE, Lustberg MB, Sucheston-Campbell LE, Cavaletti G, Sparreboom A, Hu S. Leblanc AF, et al. Among authors: de bruijn p. J Clin Invest. 2018 Feb 1;128(2):816-825. doi: 10.1172/JCI96160. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337310 Free PMC article.
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.
Hussaarts KGAM, van Doorn L, Eechoute K, Damman J, Fu Q, van Doorn N, Eisenmann ED, Gibson AA, Oomen-de Hoop E, de Bruijn P, Baker SD, Koolen SLW, van Gelder T, van Leeuwen RWF, Mathijssen RHJ, Sparreboom A, Bins S. Hussaarts KGAM, et al. Among authors: de bruijn p. Pharmaceutics. 2020 Aug 20;12(9):788. doi: 10.3390/pharmaceutics12090788. Pharmaceutics. 2020. PMID: 32825359 Free PMC article.
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio.
Lee CI, Low SK, Maldonado R, Fox P, Balakrishnar B, Coulter S, de Bruijn P, Koolen SLW, Gao B, Lynch J, Zdenkowski N, Hui R, Liddle C, Mathijssen RHJ, Wilcken N, Wong M, Gurney H. Lee CI, et al. Among authors: de bruijn p. Breast. 2020 Dec;54:229-234. doi: 10.1016/j.breast.2020.10.008. Epub 2020 Oct 21. Breast. 2020. PMID: 33161337 Free PMC article.
Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid Tumors.
Atrafi F, van Eerden RAG, van Hylckama Vlieg MAM, Oomen-de Hoop E, de Bruijn P, Lolkema MP, Moelker A, Rijcken CJ, Hanssen R, Sparreboom A, Eskens FALM, Mathijssen RHJ, Koolen SLW. Atrafi F, et al. Among authors: de bruijn p. Clin Cancer Res. 2020 Jul 15;26(14):3537-3545. doi: 10.1158/1078-0432.CCR-20-0008. Epub 2020 Apr 22. Clin Cancer Res. 2020. PMID: 32321718
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction study.
Belderbos BPS, Hussaarts KGAM, van Harten LJ, Oomen-de Hoop E, de Bruijn P, Hamberg P, van Alphen RJ, Haberkorn BCM, Lolkema MP, de Wit R, van Soest RJ, Mathijssen RHJ. Belderbos BPS, et al. Among authors: de bruijn p. Br J Clin Pharmacol. 2019 May;85(5):986-992. doi: 10.1111/bcp.13889. Epub 2019 Mar 21. Br J Clin Pharmacol. 2019. PMID: 30737835 Free PMC article. Clinical Trial.
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Braal CL, Hussaarts KGAM, Seuren L, Oomen-de Hoop E, de Bruijn P, Buck SAJ, Bos MEMM, Thijs-Visser MF, Zuetenhorst HJM, Mathijssen-van Stein D, Vastbinder MB, van Leeuwen RWF, van Gelder T, Koolen SLW, Jager A, Mathijssen RHJ. Braal CL, et al. Among authors: de bruijn p. Breast Cancer Res Treat. 2020 Nov;184(1):107-113. doi: 10.1007/s10549-020-05829-6. Epub 2020 Aug 16. Breast Cancer Res Treat. 2020. PMID: 32803636 Free PMC article.
Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study.
de Man FM, Hussaarts KGAM, de With M, Oomen-de Hoop E, de Bruijn P, van Halteren HK, van der Burg-de Graauw NCHP, Eskens FALM, van Gelder T, van Leeuwen RWF, Mathijssen RHJ. de Man FM, et al. Among authors: de bruijn p. Clin Pharmacol Ther. 2019 Jun;105(6):1456-1461. doi: 10.1002/cpt.1331. Epub 2019 Feb 10. Clin Pharmacol Ther. 2019. PMID: 30570132 Free PMC article. Clinical Trial.
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page